David J. Serisier

3.2k total citations
49 papers, 2.1k citations indexed

About

David J. Serisier is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Emergency Medical Services. According to data from OpenAlex, David J. Serisier has authored 49 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Pulmonary and Respiratory Medicine, 17 papers in Epidemiology and 11 papers in Emergency Medical Services. Recurrent topics in David J. Serisier's work include Cystic Fibrosis Research Advances (34 papers), Pneumonia and Respiratory Infections (13 papers) and Inhalation and Respiratory Drug Delivery (10 papers). David J. Serisier is often cited by papers focused on Cystic Fibrosis Research Advances (34 papers), Pneumonia and Respiratory Infections (13 papers) and Inhalation and Respiratory Drug Delivery (10 papers). David J. Serisier collaborates with scholars based in Australia, United Kingdom and United States. David J. Serisier's co-authors include Geraint B. Rogers, Kenneth D. Bruce, Megan Martin, Peter Hockey, Michael A. McGuckin, Lucy Burr, Graeme Jones, M. P. Carroll, Simon Bowler and Chris Gast and has published in prestigious journals such as JAMA, Physical review. B, Condensed matter and PLoS ONE.

In The Last Decade

David J. Serisier

48 papers receiving 2.1k citations

Peers

David J. Serisier
Rosemary Carzino Australia
Luís Máiz Spain
Mary P. Carroll United Kingdom
Marianne S. Muhlebach United States
Lisa McCloskey United States
Leah Cuthbertson United Kingdom
Marian García-Núñez Spain
Elliott C. Dasenbrook United States
Wing Ho Man Netherlands
Catherine Doherty United Kingdom
Rosemary Carzino Australia
David J. Serisier
Citations per year, relative to David J. Serisier David J. Serisier (= 1×) peers Rosemary Carzino

Countries citing papers authored by David J. Serisier

Since Specialization
Citations

This map shows the geographic impact of David J. Serisier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. Serisier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. Serisier more than expected).

Fields of papers citing papers by David J. Serisier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David J. Serisier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. Serisier. The network helps show where David J. Serisier may publish in the future.

Co-authorship network of co-authors of David J. Serisier

This figure shows the co-authorship network connecting the top 25 collaborators of David J. Serisier. A scholar is included among the top collaborators of David J. Serisier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David J. Serisier. David J. Serisier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Leong, Lex E.X., et al.. (2015). Long-Term Erythromycin Therapy Affects Microbiota Composition and Antibiotic Resistance Gene Prevalence in the Oropharynx of Bronchiectasis Patients. Respirology. 20. 29–29. 1 indexed citations
2.
Chen, Alice C.–H., Megan Martin, Rohan Lourie, et al.. (2015). Adult Non-Cystic Fibrosis Bronchiectasis Is Characterised by Airway Luminal Th17 Pathway Activation. PLoS ONE. 10(3). e0119325–e0119325. 17 indexed citations
3.
Taylor, Steven, Geraint B. Rogers, Alice C.–H. Chen, et al.. (2015). Matrix Metalloproteinases Vary with Airway Microbiota Composition and Lung Function in Non–Cystic Fibrosis Bronchiectasis. Annals of the American Thoracic Society. 12(5). 701–707. 71 indexed citations
4.
Rogers, Geraint B., Nur Masirah M. Zain, Kenneth D. Bruce, et al.. (2014). A Novel Microbiota Stratification System Predicts Future Exacerbations in Bronchiectasis. Annals of the American Thoracic Society. 11(4). 496–503. 168 indexed citations
5.
Marcos, Miguel, Lucy Burr, Rohan Lourie, et al.. (2013). Clinical Benefits Of Long-Term, Low-Dose Erythromycin In Bronchiectasis Are Not Due To Anti-Inflammatory Effects. American Journal of Respiratory and Critical Care Medicine. 187. 3 indexed citations
6.
Serisier, David J., Diana Bilton, Anthony De Soyza, et al.. (2013). Inhaled, dual release liposomal ciprofloxacin in non-cystic fibrosis bronchiectasis (ORBIT-2): a randomised, double-blind, placebo-controlled trial. Thorax. 68(9). 812–817. 181 indexed citations
7.
Serisier, David J.. (2013). Risks of population antimicrobial resistance associated with chronic macrolide use for inflammatory airway diseases. The Lancet Respiratory Medicine. 1(3). 262–274. 105 indexed citations
8.
Serisier, David J., Megan Martin, Michael A. McGuckin, et al.. (2013). Effect of Long-term, Low-Dose Erythromycin on Pulmonary Exacerbations Among Patients With Non–Cystic Fibrosis Bronchiectasis. JAMA. 309(12). 1260–1260. 283 indexed citations
9.
Serisier, David J. & Simon Bowler. (2012). Randomized Controlled Trial of Nebulized Gentamicin in Non–Cystic Fibrosis Bronchiectasis…without Patient Blinding. American Journal of Respiratory and Critical Care Medicine. 186(5). 461–461. 3 indexed citations
10.
Serisier, David J.. (2012). Inhaled antibiotics for lower respiratory tract infections: Focuson ciprofloxacin. Drugs of today. 48(5). 339–339. 18 indexed citations
11.
Serisier, David J., et al.. (2012). Antimicrobial susceptibility and synergy studies of cystic fibrosis sputum by direct sputum sensitivity testing. European Journal of Clinical Microbiology & Infectious Diseases. 31(11). 3211–3216. 11 indexed citations
12.
13.
Serisier, David J. & Megan Martin. (2011). Long-term, low-dose erythromycin in bronchiectasis subjects with frequent infective exacerbations. Respiratory Medicine. 105(6). 946–949. 43 indexed citations
14.
Serisier, David J., et al.. (2010). Safety, tolerability, pharmacokinetics and antimicrobial activity of inhaled liposomal ciprofloxacin formulations in humans. Queensland's institutional digital repository (The University of Queensland). 354–354. 3 indexed citations
15.
McCormack, J. G., Scott C. Bell, K. Walmsley, et al.. (2007). Dailyversusweekly azithromycin in cystic fibrosis patients. European Respiratory Journal. 30(3). 487–495. 37 indexed citations
16.
Serisier, David J., Andrew Coates, & Simon Bowler. (2007). Effect of Albuterol on Maximal Exercise Capacity in Cystic Fibrosis. CHEST Journal. 131(4). 1181–1187. 10 indexed citations
17.
Teo, Charles, et al.. (2005). Resolution of Trigeminal Neuralgia Following Third Ventriculostomy for Hydrocephalus Associated with Chiari I Malformation: Case Report. min - Minimally Invasive Neurosurgery. 48(5). 302–305. 17 indexed citations
18.
Serisier, David J.. (2005). Bronchial beetle. Thorax. 60(3). 262–262.
19.
Serisier, David J., Graeme Jones, Andrew Tuck, Gary Connett, & Mary P. Carroll. (2003). Clinical application of direct sputum sensitivity testing in a severe infective exacerbation of cystic fibrosis. Pediatric Pulmonology. 35(6). 463–466. 5 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rosemary Carzino Breakdown of academic impact, for papers by Luís Máiz Breakdown of academic impact, for papers by Mary P. Carroll Breakdown of academic impact, for papers by Marianne S. Muhlebach Breakdown of academic impact, for papers by Lisa McCloskey Breakdown of academic impact, for papers by Leah Cuthbertson Breakdown of academic impact, for papers by Marian García-Núñez Breakdown of academic impact, for papers by Elliott C. Dasenbrook Breakdown of academic impact, for papers by Wing Ho Man Breakdown of academic impact, for papers by Catherine Doherty
Rankless by CCL
2026